Antibodies specific for cancer associated antigen SM5-1 and uses thereof

Details for Australian Patent Application No. 2004294893 (hide)

Owner Oncomax Acquisition Corp.

Inventors Guo, Yajun; Ma, Jing

Agent Spruson & Ferguson

Pub. Number AU-A-2004294893

PCT Pub. Number WO2005/053604

Priority 092133571 28.11.03 TW; 10/722,849 26.11.03 US; 03129123.6 06.06.03 CN; 2003101199264 25.11.03 CN

Filing date 4 June 2004

Wipo publication date 16 June 2005

International Classifications

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/053604 Priority application(s): WO2005/053604

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004294894-Aerated frozen suspensions with adjusted creaminess and scoop ability based on stress-controlled generation of superfine microstructures

2004294890-Pre-metered dry powder inhaler for moisture-sensitive medicaments